Literature DB >> 20620204

Astragalus polysaccharides regulate T cell-mediated immunity via CD11c(high)CD45RB(low) DCs in vitro.

Qing-yang Liu1, Yong-ming Yao, Shu-wen Zhang, Zhi-yong Sheng.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Astragalus polysaccharides (APS) isolated from one of the Chinese herbs, Astragalus mongholicus, are known to have a variety of immunomodulatory activities. However, it is not yet clear whether APS can induce the activation and differentiation of dendritic cells (DCs) and subsequently activate T cells. AIM OF THE STUDY: This study was carried out to investigate the effect of APS on the differentiation of splenic DCs and its influence on T cell-mediated immunity through interleukin (IL)-12-producing CD11c(high)CD45RB(low) DCs in vitro.
METHODOLOGY: MACS microbeads were used to isolate splenic DCs, CD11c(high)CD45RB(low) DCs, CD11c(low)CD45RB(high) DCs and CD4(+) T cells. Phenotypes were analyzed by flow cytometry, and cytokine levels were determined with cytometric bead array or ELISA. RESULT: The percentage of CD11c(high)CD45RB(low) DCs was significantly increased after treatment with APS compared to their counterparts. The cytokine secretion pattern of CD11c(high)CD45RB(low) DCs and CD11c(low)CD45RB(high) DCs was detected, and it was found that unlike the stable IL-10 secretion pattern of CD11c(low)CD45RB(high) DCs induced by APS, CD11c(high)CD45RB(low) DCs showed a dose-dependent relationship between IL-12 production and APS stimulation. In order to verify whether the activation of CD4(+) T was associated with the differentiation of splenic DCs mediated by APS to CD11c(high)CD45RB(low) DCs, anti-IL-12 receptor (IL-12R) as well as anti-IL-10R monoclonal antibody was used to inhibit the effect of CD11c(high)CD45RB(low) DCs and CD11c(low)CD45RB(high) DCs in CD4(+) T mixed lymphocyte reaction culture. After treatment with anti-IL-12R or anti-IL-10 monoclonal antibody in CD4(+) T+CD11c(high)CD45RB(low) DCs or CD11c(low)CD45RB(high) DCs mixed lymphocyte reaction, the inductions of these DCs on T cells were inhibited dramatically.
CONCLUSION: APS might induce the differentiation of splenic DCs to CD11c(high)CD45RB(low) DCs followed by shifting of Th2 to Th1 with enhancement of T lymphocyte immune function in vitro. Also, the effect of APS on T-cell differentiation to Th1 was not associated with the inhibition of IL-10 production in CD11c(low)CD45RB(high) DCs.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620204     DOI: 10.1016/j.jep.2010.06.041

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  23 in total

1.  Astragalus polysaccharide attenuates lipopolysaccharide-induced inflammatory responses in microglial cells: regulation of protein kinase B and nuclear factor-κB signaling.

Authors:  Tao Luo; Jian Qin; Min Liu; Jun Luo; Fang Ding; Mingling Wang; Limin Zheng
Journal:  Inflamm Res       Date:  2015-02-11       Impact factor: 4.575

2.  Astragalus on the anti-fatigue effect in hypoxic mice.

Authors:  Gang Zhang; Si-Min Zhou; Shan-Jun Zheng; Fu-Yu Liu; Yu-Qi Gao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival.

Authors:  Li Guo; Shu-Ping Bai; Ling Zhao; Xiao-Hong Wang
Journal:  Med Oncol       Date:  2011-09-18       Impact factor: 3.064

Review 4.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 5.  Astragalus polysaccharide: a review of its immunomodulatory effect.

Authors:  Chun-Xiao Li; Ying Liu; Yu-Zhen Zhang; Jing-Chun Li; Jiang Lai
Journal:  Arch Pharm Res       Date:  2022-06-17       Impact factor: 4.946

6.  Astragalus polysaccharides suppress ICAM-1 and VCAM-1 expression in TNF-α-treated human vascular endothelial cells by blocking NF-κB activation.

Authors:  Yu-ping Zhu; Tao Shen; Ya-jun Lin; Bei-dong Chen; Yang Ruan; Yuan Cao; Yue Qiao; Yong Man; Shu Wang; Jian Li
Journal:  Acta Pharmacol Sin       Date:  2013-06-03       Impact factor: 6.150

7.  Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells.

Authors:  Qing-yang Liu; Yong-ming Yao; Yan Yu; Ning Dong; Zhi-yong Sheng
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

8.  Characterization and lymphocyte proliferation activity of an oligosaccharide degraded from Astragalus polysaccharide.

Authors:  Zhen-Yuan Zhu; Jin-Yu Zhang; Fei Liu; Ling Chen; Li-Jing Chen; Yun Tang
Journal:  Medchemcomm       Date:  2017-06-14       Impact factor: 3.597

9.  Response of Growth Performance, Blood Biochemistry Indices, and Rumen Bacterial Diversity in Lambs to Diets Containing Supplemental Probiotics and Chinese Medicine Polysaccharides.

Authors:  Huan Chen; Beibei Guo; Mingrui Yang; Junrong Luo; Yiqing Hu; Mingren Qu; Xiaozhen Song
Journal:  Front Vet Sci       Date:  2021-06-24

10.  Astragalus root and elderberry fruit extracts enhance the IFN-β stimulatory effects of Lactobacillus acidophilus in murine-derived dendritic cells.

Authors:  Hanne Frøkiær; Louise Henningsen; Stine Broeng Metzdorff; Gudrun Weiss; Marc Roller; John Flanagan; Emilie Fromentin; Alvin Ibarra
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.